ALNY — Alnylam Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapHigh Flyer

Annual balance sheet for Alnylam Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1,874	2,436	2,192	2,439	2,695
Net Total Accounts Receivable
Net Total Receivables	602	199	238	328	405
Total Inventory
Prepaid Expenses
Total Current Assets	2,615	2,809	2,692	2,983	3,295
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	707	734	739	726	694
Other Long Term Assets
Total Assets	3,407	3,643	3,546	3,830	4,240
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	585	696	768	968	1,186
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	2,391	3,055	3,705	4,051	4,173
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	1,016	588	-158	-221	67.1
Total Liabilities & Shareholders' Equity	3,407	3,643	3,546	3,830	4,240
Total Common Shares Outstanding